https://www.nytimes.com/2026/07/15/well/mind/alzheimers-disease-blood-tests-symptoms.html
Posts Tagged ‘AD’
Alzheimer’s Blood Tests Offer New Promise to Diagnose and Predict the Disease – The New York Times
July 19, 2026Nature medcine “A minimally invasive dried blood spot biomarker test for the detection of Alzheimer’s dis ease pathology”
January 26, 2026QT:{{”
The DROP-AD project investigates the potential of dried plasma spot (DPS) and dried blood spot (DBS) analysis, derived from capillary blood, for detecting AD biomarkers, including phosphorylated tau at amino acid 217 (p-tau217), glial fibrillary acidic protein and neurofilament light. …. Similarly, we demonstrated the successful detection of glial fibrillary acidic protein and neurofilament light with strong correlations between DBS and DPS, respectively, using paired venous plasma samples.
“}}
Might find this paper very interesting. Just published this month in Nature Medicine. “A minimally invasive dried blood spot biomarker test for the detection of Alzheimer’s disease pathology.”
A minimally invasive dried blood spot biomarker test for the detection of Alzheimer’s disease pathology – Nature Medicine
https://www.nature.com/articles/s41591-025-04080-0
Frontotemporal dementia – Wikipedia
May 18, 2025https://en.wikipedia.org/wiki/Frontotemporal_dementia
Pick’s disease
Type 3 Diabetes and Its Role Implications in Alzheimer’s Disease – PMC
February 24, 2025How a new kind of vaccine could lead to the eradication of Alzheimer’s and dementia | New Scientist
November 10, 2024Has Alzheimer’s met its match? – ScienceDirect
February 29, 2024https://www.sciencedirect.com/science/article/abs/pii/S0262407923009429?via%3Dihub
New Scientist
Volume 258, Issue 3440, 27 May 2023, Pages 14-15
Has Alzheimer’s met its match?
Clare Wilson
Conquering Alzheimer’s: a look at the therapies of the future
May 29, 2023https://www.nature.com/articles/d41586-023-00954-w
lecanemab is one of the new drugs
Cholesterol and dementia | Alzheimer’s Society
May 12, 2023https://www.alzheimers.org.uk/about-dementia/risk-factors-and-prevention/cholesterol-and-dementia
QT:{{”
A meta-analysis is a study that looks at lots of previous studies and analyses all of the data together to increase the number of people studied and to look at the information in a consistent way. A meta-analysis looking at observational studies investigating statins and the risk of dementia looked at data from 11 studies, involving over 23,000 participants, who had been taking statins for between 3 and nearly 25 years on average. When all of the data was analysed together, the researchers found that those people taking statins had a 29 per cent reduced risk of developing dementia.
“}}
linkstream2 microblog 